Filing Details

Accession Number:
0001232524-12-000054
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-13 19:31:50
Reporting Period:
2012-03-09
Filing Date:
2012-03-13
Accepted Time:
2012-03-13 19:31:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1092348 Alan Sebulsky C/o Jazz Pharmaceuticals Plc
45 Fitzwilliam Square
Dublin 2 L2
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2012-03-09 31,166 $49.56 54,355 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. On March 9, 2012, the Reporting Person completed the sale of 31,166 ordinary shares to Barclays Capital Inc. and Citigroup Global Markets Inc., as underwriters in connection with a public offering of a total of 7,883,366 ordinary shares by certain shareholders of the Issuer, including the Reporting Person.